Information  X 
Enter a valid email address

Primary Health Props (PHP)

  Print      Mail a friend

Monday 16 March, 2020

Primary Health Props

Rule 19.6(c) Confirmation

RNS Number : 1739G
Primary Health Properties PLC
16 March 2020
 

THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE REQUIREMENTS OF RULE 19.6(C) OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"), WHICH, INTER ALIA, REQUIRES A PARTY TO AN OFFER TO MAKE AN ANNOUNCEMENT AT THE END OF A PERIOD OF 12 MONTHS FROM THE DATE ON WHICH THE OFFER PERIOD ENDED CONFIRMING WHETHER IT HAS TAKEN, OR NOT TAKEN, THE COURSE OF ACTION SET OUT IN ITS STATED INTENTIONS.

 

Primary Health Properties PLC

Rule 19.6(c) confirmation with respect to stated post-offer intentions with regard to MedicX Fund Limited

 

Primary Health Properties PLC (the "Company") announces that further to the completion of its recommended all-share merger with MedicX Fund Limited, which was effected by way of a scheme of arrangement under Part 26 of the Companies Act 2006 on 14 March 2019, the Company has duly confirmed in writing to The Panel on Takeovers and Mergers in accordance with the requirements of Rule 19.6(c) of the Code that it has complied with its post-offer statements of intent made pursuant to Rules 2.7(c)(iv) and 24.2 of the Code, as originally detailed in its announcement of 24 January 2019 and the scheme document published on 8 February 2019.

 

More information on Primary Health Properties PLC can be found on  www.phpgroup.co.uk

 

Further details:

 

Harry Hyman

Managing Director

Tel: +44 (0) 20 7451 7050

Richard Howell

Finance Director

Tel: +44 (0) 20 7104 5599



 

David Rydell / Steph Watson / Tilly Abraham
(Buchanan Communications)

Tel: +44 (0) 20 7466 5066



 


Legal Entity Identifier: 213800Y5CJHXOATK7X11

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
OUPMZGMFNFMGGZM

a d v e r t i s e m e n t